{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T11:18:29Z","timestamp":1707995909268},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Modern Rheumatology"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.3109\/s10165-003-0250-9","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T14:50:50Z","timestamp":1388674250000},"page":"319-325","source":"Crossref","is-referenced-by-count":8,"title":["Prospective study of high-dose intravenous immunoglobulin for the treatment of steroid-resistant polymyositis and dermatomyositis"],"prefix":"10.1093","volume":"13","author":[{"given":"Masako","family":"Hara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eizo","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Miyasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukinobu","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadao","family":"Kashiwazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,1,2]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0046-8177(86)80180-0","volume":"17","author":"Engel AG","year":"1986","journal-title":"Human Pathol"},{"key":"CIT0002","first-page":"224","volume":"20","author":"Emslie-Smith AM","year":"1989","journal-title":"Major histocompatibil-ity complex class I antigen expression, immunolocalization of in-terferon subtypes, and T cell-mediated cytotoxicity in myopathies. Human Pathol"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ana.410290509","volume":"29","author":"Hohlfeld R","year":"1991","journal-title":"Ann Neurol"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1084\/jem.181.5.1863","volume":"181","author":"Bender A","year":"1995","journal-title":"J Exp Med"},{"key":"CIT0005","first-page":"1178","volume":"146","author":"DeBleecker JL","year":"1995","journal-title":"Am J Pathol"},{"key":"CIT0006","first-page":"421","volume":"41","author":"Lidberg C","year":"1995","journal-title":"Local T-cell proliferation and differentiation in inflammatory myopathies. Scand J Immunol"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197202172860701"},{"key":"CIT0008","first-page":"329","volume":"314","author":"Kissel JT","year":"1986","journal-title":"Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med"},{"key":"CIT0009","first-page":"343","volume":"27","author":"Emslie-Smith AM","year":"1990","journal-title":"AG. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol"},{"key":"CIT0010","first-page":"292","volume":"22","author":"Casademont J","year":"1993","journal-title":"Analysis of the outcome of idiopathic inflammatory myopathies with particular emphasis on muscle capillary damage. Scand J Ftheumatol"},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00002281-199611000-00005","volume":"8","author":"Minori T","year":"1996","journal-title":"Curr Opin Ftheumatol"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00002281-200011000-00001","volume":"12","author":"Targoff IN","year":"2000","journal-title":"Curr Opin Ftheumatol"},{"key":"CIT0013","first-page":"513","volume":"258","author":"Roifman CM","year":"1987","journal-title":"Reversal of chronic polymyositis following intrave-nous immune serum globulin therapy. JAMA"},{"key":"CIT0015","first-page":"169","volume":"91","author":"Lang BA","year":"1991","journal-title":"Treatment of dermatomyositis with intravenous gammaglobulin. Am J Med"},{"key":"CIT0016","first-page":"60","volume":"55","author":"Jan S","year":"1992","journal-title":"High-dose intravenous human immunoglobulin in polymyositis resistant to treatment. J Neurol Neurosurg Psychiatry"},{"key":"CIT0017","first-page":"1979","volume":"137","author":"Breems DA","year":"1993","journal-title":"Ned Tijdschr Geneeskd"},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2133.1994.tb02906.x","volume":"130","author":"Collet E","year":"1994","journal-title":"Br J Dermatol"},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/adc.72.1.25","volume":"72","author":"Sansome A","year":"1995","journal-title":"Arch Dis Child"},{"issue":"1","key":"CIT0021","first-page":"48","volume":"151","author":"Cherin P","year":"2000","journal-title":"Ann Med Interne"},{"key":"CIT0022","first-page":"1144","volume":"21","author":"Reimold AM","year":"1994","journal-title":"J Ftheumatol"},{"key":"CIT0024","first-page":"663","volume":"35","author":"Moriguchi M","year":"1996","journal-title":"Intra-venous immunoglobulin therapy for refractory myositis. Intern Med"},{"key":"CIT0026","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"Bohan A","year":"1975","journal-title":"N Engl J[Med]"},{"key":"CIT0027","first-page":"521\ufffd6","volume":"15","author":"Kinoshita M","year":"1998","journal-title":"Highdose[intravenous] immunoglobulin infusion therapy for steroidrefractory[polymyositis] and dermatomyositis (in Japanese). Neurol[Ther]"},{"key":"CIT0028","doi-asserted-by":"crossref","first-page":"55\ufffd60","DOI":"10.1111\/cei.1996.104.s1.55","volume":"104","author":"Dalakas MC","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"CIT0029","first-page":"1228\ufffd31","volume":"1","author":"Imbach P","year":"1981","journal-title":"High-dose intravenous gammaglobulin for idiopathic[thrombocytopenic] purpura in childhood. Lancet"},{"key":"CIT0030","first-page":"1179\ufffd83","volume":"64","author":"Pizzuto J","year":"1984","journal-title":"[Blood]"},{"key":"CIT0031","first-page":"1123\ufffd9","volume":"326","author":"Von der Mecher FGA, Schmitz PIM,","year":"1992","journal-title":"A randomized trial comparing intravenous immune[globulin] and plasma exchange in Guillain\ufffdBarre syndrome. N Eng[J] Med"},{"key":"CIT0032","first-page":"139\ufffd52","volume":"26","author":"Bril V","year":"1999","journal-title":"IVIG[in] neurology: evidence and recommendation. Can J Neurol Sci"},{"key":"CIT0033","first-page":"136\ufffd47","volume":"20","author":"Von der Mecher FGA, van Doorn PA.","year":"1997","journal-title":"[Muscle] Nerve"},{"key":"CIT0034","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7326\/0003-4819-126-9-199705010-00008","volume":"126","author":"Dalakas MC","year":"1997","journal-title":"Ann Intern Med"},{"key":"CIT0035","first-page":"128\ufffd31","volume":"11","author":"Liblau R","year":"1991","journal-title":"Bach JF, Morel E.[Intravenous] gamma-globulin in myastemia gravis: interaction[with] anti-acetylcholine receptor autoantibodies. J Clin Immunol"},{"key":"CIT0036","first-page":"433","volume":"93","author":"Jayne DRW","year":"2000","journal-title":"Intravenous immunoglobulin for ANCA-associated[systemic] vasculitis with persistent disease activity. Q J Med"},{"key":"CIT0037","first-page":"1055\ufffd8","volume":"2","author":"Furusho K","year":"1984","journal-title":"High-dose intravenous gammaglobulin for[Kawasaki] disease. Lancet"},{"key":"CIT0038","first-page":"341\ufffd7","volume":"315","author":"Newburger JW","year":"1986","journal-title":"The treament of Kawasaki syndrome with intravenous[gammaglobulin]. N Engl J Med"},{"key":"CIT0039","first-page":"421\ufffd6","volume":"39","author":"Sherer Y","year":"2000","journal-title":"Intravenous immunoglobulin[therapy] of antiphospholipid syndrome. Rheumatology"},{"key":"CIT0041","first-page":"305\ufffd10","volume":"6","author":"Sany J","year":"1994","journal-title":"[Curr] Opin Rheumatol"},{"key":"CIT0042","first-page":"295\ufffd9","volume":"7","author":"Corvetta A","year":"1989","journal-title":"G.[Use] of high-dose intravenous immunoglobulin in systemic lupus[erythematosus] : report of three cases. Clin Exp Rheumatol"},{"key":"CIT0043","doi-asserted-by":"crossref","first-page":"21\ufffd5","DOI":"10.1046\/j.1365-2249.1996.23730.x","volume":"104","author":"Basta M","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"CIT0044","first-page":"151\ufffd7","volume":"100","author":"Ballow M","year":"1997","journal-title":"J Allergy Clin[Immunol]"},{"key":"CIT0045","first-page":"227\ufffd8","volume":"340","author":"Yu Z","year":"1999","journal-title":"N Engl J Med"},{"key":"CIT0046","doi-asserted-by":"crossref","first-page":"137\ufffd44","DOI":"10.1016\/S0165-5728(00)00210-1","volume":"106","author":"Stangel M","year":"2000","journal-title":"J Neuroimmunol"},{"key":"CIT0047","first-page":"587\ufffd91","volume":"14","author":"DeKeyser F","year":"1996","journal-title":"Pooled human immunogobulins contain anti-idiotype.[Clin] Exp Rheumatol"},{"key":"CIT0048","doi-asserted-by":"crossref","first-page":"2414\ufffd7","DOI":"10.1182\/blood.V74.7.2414.2414","volume":"74","author":"Berchtold P","year":"1989","journal-title":"Blood"},{"key":"CIT0049","first-page":"298\ufffd303","volume":"83","author":"Rossi F","year":"1991","journal-title":"Clin Exp[Immunol]"},{"key":"CIT0050","first-page":"2533","volume":"92","author":"Svenson M","year":"1993","journal-title":"Binding of cytokines to[pharmaceutically] prepared human immunoglobulin. J Clin Invest"},{"key":"CIT0051","first-page":"21\ufffd42","volume":"139","author":"Andersson U","year":"1994","journal-title":"Pool[human] IgG-modulated cytokine production in lymphocytes and[monocytes]. Immunol Rev"},{"key":"CIT0052","first-page":"5\ufffd19","volume":"139","author":"Abe Y","year":"1994","journal-title":"Immunol[Rev]"},{"key":"CIT0054","doi-asserted-by":"crossref","first-page":"153\ufffd6","DOI":"10.1177\/135245859700300218","volume":"3","author":"Pashov A","year":"1997","journal-title":"Mult Scler"},{"key":"CIT0056","first-page":"1833\ufffd8","volume":"52","author":"Sharief MK","year":"1999","journal-title":"Neurology"},{"key":"CIT0059","first-page":"152\ufffd8","volume":"11","author":"Kindo N","year":"1991","journal-title":"Suppression of immunoglobulin production[of] lymphocytes by intravenous immunoglobulin. J Clin Immunol"},{"key":"CIT0060","doi-asserted-by":"crossref","first-page":"99\ufffd104","DOI":"10.1006\/clim.1999.4823","volume":"94","author":"Amemiya K","year":"2000","journal-title":"Clin Immunol"},{"key":"CIT0061","first-page":"1729\ufffd35","volume":"94","author":"Basta M","year":"1994","journal-title":"[J] Clin Invest"},{"key":"CIT0062","first-page":"282\ufffd9","volume":"124","author":"Wada J","year":"2001","journal-title":"[Intravenous] immunoglobulin prevents experimental autoimmune[myositis] in SJL mice by reducing antimyosin antibody and by[blocking] complement deposition. Clin Exp Immunol"},{"key":"CIT0064","first-page":"674\ufffd7","volume":"47","author":"Brannagan TH","year":"1996","journal-title":"Complication[of] intravenous immune globulin treatment in neurologic[disease]. Neurology"},{"key":"CIT0065","first-page":"1563\ufffd7","volume":"276","author":"Bresee JS","year":"1996","journal-title":"Hepatitis C virus infection associated with administration[of] intravenous immune globulin: cohort study. JAMA"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/s10165-003-0250-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T02:52:03Z","timestamp":1642560723000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/13\/4\/319-325\/6313533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,1,2]]},"published-print":{"date-parts":[[2003,12]]}},"alternative-id":["10.3109\/s10165-003-0250-9"],"URL":"https:\/\/doi.org\/10.3109\/s10165-003-0250-9","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}